Gwen Hyland

Head, Global Commercial Excellence at Alexion, AstaZeneca Rare Disease

Speaker

Gwen Hyland currently serves as the Head of Global Commercial Excellence for the Global Marketing & Commercial Strategy team within Alexion, AstraZeneca Rare Disease. This team exists at a critical intersection between the cross-functional teams driving the rare disease pipeline forward and the regions and countries winning in the market. In this role, Gwen leads a brilliant team of collaborators focused on insight generation, competitive intelligence, portfolio analytics/forecasting, launch excellence, and cross-portfolio capability development.

Prior to Alexion, Gwen worked in strategy and management consulting, serving as a trusted advisor to senior leaders in biopharmaceutical and life sciences to design, implement, and sustain strategic and transformational initiatives. Before that, Gwen worked in health policy.